Background: Vitamin D is the main hormone that plays a critical role in controlling mineral homeostasis. Transplant recipients frequently have altered levels of 25-hydroxyvitamin D (25[OH] D) and 1, 25-hydroxyvitamin (1, 25[OH] D).
Objectives: To explore the status of vitamin D level in renal allograft recipients and its association with renal function and cardio-metabolic risk markers.